Alexandra Hansen, The Conversation and Wes Mountain, The Conversation
The annual surveillance report of sexually transmissible infections and blood borne viruses in Australia has found notifications of sexually transmissible infections are on the rise in Australia.
HIV diagnosis is devastating for patients and their families. But the infection is no longer a death sentence, and should not be prosecuted as such say experts.
When people migrate they can end up worse off when it comes to getting access to health care. Analysing migration trends can help drive local public health policy towards the correct targets.
Two musicals set in working class mining communities – one in the UK and the other in South Africa – have diametrically opposed messages: one of hope; the other, despair.
Studies have suggested that women using a particular kind of injectable contraceptive are more susceptible to HIV infection. Research in mice offers new insights.
Worldwide, around 30 million people enter and leave prison each year. Of these people, around 4.5 million have hepatitis C, almost 1 million have HIV and 1.5 million have hepatitis B infections.
Glenda Gray, South African Medical Research Council
The 90-90-90 strategy is an attempt to get the HIV epidemic under control by adopting a ‘test and treat’ approach. This is part of the plan to eliminate AIDS by 2030.
In the the wake of the Orlando massacre, many people directly affected by this homophobic hate crime are prevented from offering help due to homophobic regulations.
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand